Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia
Udaya RajBhandari, Associate Researcher at T.U. Lions Blood Transfusion and Research Centre, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Grande Medical Journal, adding:
“I’m pleased to share that our another case report, ‘Anti-c Alloimmunization Causing Acute Hemolytic Transfusion Reaction in a Chronically Transfused β-Thalassemia Patient: A Case Report,’ has been published in the Grande Medical Journal.
This case highlights the importance of RBC antibody screening, antibody identification, and antigen-negative blood selection, particularly in patients requiring repeated transfusions.”
Title: Anti-c Alloimmunization Associated with Acute Hemolytic Transfusion Reaction in a Chronically Transfused β-Thalassemia Patient: A Case Report
Authors: Udaya Prakash Bhandari, Sabindra Maharjan, Sunil Bhasima, Bipin Nepal
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:06Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:04Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?
-
Sep 23, 2026, 00:02Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:57Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation